Baltimore-based Lupin Pharmaceuticals earned approval from the Food and Drug Administration for its armodafinil tablets.
According to a news release, the tablets are intended to improve wakefulness in adults with excessive sleepiness caused by various sleep disorders.
Armodafinil tablets are the generic equivalent of Cephalon's Nuvigil tablets.
More articles on supply chain:
4 threats to the US blood supply
FDA approves Lanett's muscle relaxant drug: 3 things to know
Addiction centers pay more than $700k to resolve allegations of improper prescribing